UpCoin Media@UpCoinMedia · 15h
BYSI Stock Falls to New Session Low of $0.64
BYSI is trading lower today at $0.64 (-7.1%).
#MarketAlert
BYSI
0 followers
Currency
Monetary values are shown in your selected currency.
Stock Movement
Profit Simulator
Thursday, August 27
Low
$0.5666
High
$0.6825
Cost of Shares
—
Simulated Profit
—
Simulated results compare the selected period's low and high and do not represent an actual trade. Fees, taxes, slippage, and the ability to execute at exact prices are not included.
Community-Reported Results
Reported Profit
$0
0 profit reports
Reported Loss
$0
0 loss reports
Net Reported
$0
0 total reports
Community Outlook
No community outlook yet.
Be the first to vote when a poll becomes available.
0Followers0Active Polls7Recent Posts$0Reported Net
Latest â–¾
Low
UpCoin Media@UpCoinMedia · 16h
BeyondSpring (BYSI) Reports Recent Clinical Trial Updates
BeyondSpring (BYSI) recently shared updated efficacy and safety data from a Phase 2 clinical study. The trial evaluates the combination of pembrolizumab with Plinabulin and docetaxel for the treatment of metastatic lung cancer. The company continues to focus on the development of its lead asset, Plinabulin, and recently reported its second-quarter 2026 financial results. No immediate regulatory warnings or dilution events were identified in recent filings.
#BYSI#Biotech#ClinicalTrials
Bearish
UpCoin Media@UpCoinMedia · 16h
BeyondSpring (BYSI) Reports Financial Results and Going Concern Warning
BeyondSpring (BYSI) filed its quarterly report on August 14, 2026. The company reported a net loss of $1.8 million for the second quarter of 2026. It currently holds $6.5 million in cash and short-term investments. Management stated that recurring losses and negative working capital create doubt about the company's ability to continue operations without raising more money. The company remains focused on the clinical development of its cancer therapy, Plinabulin. Why it matters: The warning about the company's ability to continue as a going concern highlights significant financial risk for investors.
#BYSI#Biotech#Investing
UpCoin Media@UpCoinMedia · 16h
BYSI Stock Opens at $0.6924
BYSI opened today's regular trading session at $0.6924, compared with its previous close of $0.6900. Opening difference: +0.3% Why it matters: The stock began trading 0.3% above its previous close.
#MarketOpen#PennyStocks
UpCoin Media@UpCoinMedia · 17h
BeyondSpring (BYSI) Reports Second-Quarter 2026 Financial Results
BeyondSpring (BYSI) released its financial results for the second quarter of 2026. The company reported a net loss of $1.8 million from continuing operations. As of June 30, 2026, the company held $6.5 million in cash, cash equivalents, and short-term investments. The company is currently preparing for its 442-patient confirmatory DUBLIN-4 Phase 3 clinical study for its lead asset, Plinabulin. Why it matters: The company is managing its cash reserves while continuing to advance its oncology drug development pipeline.
#BYSI#Biotech#Stocks
UpCoin Media@UpCoinMedia · 17h
BYSI Support and Resistance Levels to Watch Today
Support: $0.6700–$0.6800 Resistance: $1.32–$1.35 Why it matters: BYSI has recently reacted near these areas, making them useful levels to watch during today's session.
#Support#Resistance
UpCoin Media@UpCoinMedia · 17h
BYSI Stock Levels From the Previous Trading Day
High: $0.7200 Low: $0.6880 Close: $0.6900 Daily range: $0.0320 Why it matters: BYSI finished the previous session in the lower portion of its trading range.
#MarketLevels#PennyStock
Community sentiment and reported results reflect voluntary member input and should not be interpreted as investment advice or verified performance.